Macciardi F, Verga M, Kennedy J L, Petronis A, Bersani G, Pancheri P, Smeraldi E
Department of Neuropsychiatric Science, Istituto Scientifico H. San Raffaele, Milan, Italy.
Hum Hered. 1994 Nov-Dec;44(6):328-36. doi: 10.1159/000154240.
Our work investigates the relationship between genetic factors and schizophrenia, seeking to identify a gene or genes associated with the clinical form of the disease in a group of Italian patients. In pursuit of the 'dopaminergic hypothesis' of schizophrenia, we explored a possible etiologic role of two dopamine receptor genes, DRD3 and DRD4, that have been repeatedly suggested as factors in the pathophysiology of the disease. We typed DNA polymorphisms in each of the genes that code for variation in the amino acid sequence of the receptor protein. An innovative design using parental chromosomes as controls--the 'haplotype relative risk' strategy--represents a significant improvement over previous association studies in psychiatric genetics. Our results suggest that, at least in our well-defined population, the candidate genes DRD3 and DRD4 do not appear to play a major role in the genetic etiology of schizophrenia.
我们的研究旨在调查遗传因素与精神分裂症之间的关系,试图在一组意大利患者中识别出与该疾病临床形式相关的一个或多个基因。为了探寻精神分裂症的“多巴胺能假说”,我们研究了两个多巴胺受体基因DRD3和DRD4可能的病因学作用,这两个基因多次被认为是该疾病病理生理学的影响因素。我们对每个编码受体蛋白氨基酸序列变异的基因中的DNA多态性进行了分型。一种将亲本染色体用作对照的创新设计——“单倍型相对风险”策略——相较于先前精神疾病遗传学的关联研究有了显著改进。我们的结果表明,至少在我们明确界定的人群中,候选基因DRD3和DRD4似乎在精神分裂症的遗传病因学中并不起主要作用。